SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 13, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 4h ago
Insider cluster: 2 insiders, $173K total
Actionable Insight • Neutral

The sales are immaterial in size and executed under pre-arranged 10b5-1 plans. No signal for stock direction. Monitor next earnings or pipeline catalyst for material insider activity.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Oruka Therapeutics (ORKA) executed open-market sales totaling $173K on November 12, 2026, both under 10b5-1 plans. Director Kristine M. Ball sold $122K and SVP Arjun Agarwal sold $51K. The combined sales represent less than 0.01% of the company's $7.3B market cap, making the cluster trivial in scale.

Key Financial Metrics

Direction
selling
Total Value
$173.1K
Insiders
2

Key Facts

  • Two insiders sold shares on November 12, 2026
  • Director Kristine M. Ball sold 1,200 shares for $122,108 (10b5-1 plan)
  • SVP Arjun Agarwal sold 500 shares for $50,988 (10b5-1 plan)
  • Total open-market sales: $173,096
  • Sales represent less than 0.01% of $7.3B market cap
  • Both sales were under 10b5-1 trading plans

Financial Impact

Total insider sales of $173K, negligible relative to $7.3B market cap

Risk Factors

  • Sales are trivial and routine; no material risk identified

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1794618268500

Track record

40 reports on ORKA

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Viewing Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 8h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026